Ryo Hanajiri

837 citations
29 papers · 576 indexed · h-index 10
Topics
CAR-T cell therapy research (15 papers)Immune Cell Function and Interaction (7 papers)Hematopoietic Stem Cell Transplantation (6 papers)

In The Last Decade

Ryo Hanajiri

27 papers receiving 567 citations

Peers

Ryo Hanajiri
Comparison fields: 5 of 49
  • Oncology 452
  • Immunology 200
  • Genetics 170
  • Biomedical Engineering 163
  • Molecular Biology 162
Replace Sabine Heitzeneder with:
Sabine Heitzeneder United States
John Craddock United States
Theresa Kaeuferle Germany
Degui Geng United States
Anna Capsomidis United Kingdom
Thomas Shum United States
Daniel Hollyman United Kingdom
Fenlu Zhu United States
Justin C. Boucher United States
Vicky Torrano United States
Ryo Hanajiri relative to Sabine Heitzeneder United States Sabine Heitzeneder's profile →
Citations per field
00.5×1.5×2.1×
Sabine Heitzeneder · 1×
Citations per year

Countries citing papers authored by Ryo Hanajiri

Since Specialization
Citations

This map shows the geographic impact of Ryo Hanajiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Hanajiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Hanajiri more than expected).

Fields of papers citing papers by Ryo Hanajiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Hanajiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Hanajiri. The network helps show where Ryo Hanajiri may publish in the future.

Co-authorship network of co-authors of Ryo Hanajiri

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Hanajiri. A scholar is included among the top collaborators of Ryo Hanajiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Hanajiri. Ryo Hanajiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 7
4 9
5 1
6 3
7 30
8 9
9 13
10 16
11 11
12 2
13 3
14 129
15 20
16 13
17 4
18 5
19 223
20 3

About Ryo Hanajiri

Ryo Hanajiri is a scholar working on Transplantation, Oncology and Hematology, having authored 29 papers that have together received 576 indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). The work is most often cited by research in Oncology (452 citations), Immunology (200 citations) and Genetics (170 citations). Ryo Hanajiri has collaborated with scholars based in Japan, United States and Austria. Frequent co-authors include Makoto Murata, Seitaro Terakura, Hitoshi Kiyoi, Tatsunori Goto, Tetsuya Nishida, Reona Sakemura, Keisuke Watanabe, Nobuhiko Imahashi, Daisuke Koyama and Kotaro Miyao. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026